This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therapy | MicrobiomeTrials

NCT07263620

An Exploratory Study on Microbial Biomarkers Associated With the Efficacy of Neoadjuvant Therapy

RecruitingOBSERVATIONAL

Trial Details

Start: 2025-10-01Est. Completion: 2026-01-30

Enrollment target: 90 participants

Locations

Patients with esophageal, pancreatic, gastric, or colorectal cancer who are scheduled to receive neoadjuvant therapy, Tianjin, China

Contact

Chronic Hepatitis B e Antigen PositiveChronic Hepatitis B e Antigen Negative

Background: \- Chronic infection with the hepatitis B virus may lead to cirrhosis, liver disease, and cancer of the liv…

Bethesda, United States

Metastatic Colorectal CancerCRCKRAS/NRAS Mutation

The purpose of this study is to assess 2 different doses of onvansertib to select the lowest dose that is maximally effe…

Phoenix, United StatesEst. completion Nov 2026

Endocrine TumorsThyroid NeoplasmsParathyroid NeoplasmsAdrenal NeoplasmNeuroblastoma

Background: * Endocrine neoplasms (tumors) are among the fastest growing tumors in incidence in the United States. Furt…

Bethesda, United States

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.